Objective The impact of the intrathecal infusion port system on patients with advanced cancer pain and the nursing workload on their primary caregivers was investigated in this study. Methods Between January 2018 and December 2021, a total of 26 patients with advanced cancer pain who received intrathecal infusion in our hospital, were enrolled in this study along with their primary caregivers. Assessments of patients’ pain levels, adverse reactions, and quality of life, as well as the nursing workload of primary caregivers were evaluated. Results The findings revealed a significant reduction in pain scores, decreasing from (7.42 ± 0.58) one week before treatment to (2.00 ± 0.56) one week after treatment, and maintaining a similar level at (2.07 ± 0.56) one month post-treatment, with a concomitant decrease in associated complications. Moreover, an improvement in overall quality of life was observed, as evident in the total physical health scores, which increased from (33.97 ± 7.14) one week prior to treatment to (47.44 ± 10.14) one week post-treatment and (48.56 ± 9.35) one month post-treatment. The total psychological health scores exhibited a positive trajectory, rising from (52.50 ± 23.55) one week before treatment to (65.00 ± 16.55) one week after treatment, ultimately reaching (69.42 ± 15.64) one month post-treatment. Furthermore, the primary caregivers’ nursing workload experienced a consistent decline, decreasing from (51.54 ± 7.30) one week before treatment to (46.54 ± 5.57) one week after treatment and further diminishing to (45.32 ± 6.41) one month after treatment. Repeated measures of variance showed that there were significant differences in pain, quality of life, and primary caregivers’ nursing workload at different time points ( P < 0.05). Conclusion The intrathecal infusion port system can effectively reduce the pain level of patients with advanced cancer pain, improve their quality of life, and reduce the nursing workload of their primary caregivers.
Read full abstract